Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B VanLunen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Orthopaedic and Sports Physical Therapy|May 1, 1997
Pondering plyometricsG Ernst, J Moore, B VanLunen, et al.
Annals of the Rheumatic Diseases|May 12, 2016
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III studyP Emery, C O Bingham, G R Burmester, et al.
Annals of the Rheumatic Diseases|August 14, 2016
Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by BoersP Emery, C O Bingham, G R Burmester, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Orthopaedic and Sports Physical Therapy|May 1, 1997
Pondering plyometricsG Ernst, J Moore, B VanLunen, et al.
Annals of the Rheumatic Diseases|May 12, 2016
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III studyP Emery, C O Bingham, G R Burmester, et al.
Annals of the Rheumatic Diseases|August 14, 2016
Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by BoersP Emery, C O Bingham, G R Burmester, et al.
Pageof 1